Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-01-07Clinical Trial Update: Adjuvant Chemotherapy With Docetaxel, Capecitabine and Cisplatin in Patients With Advanced Gastric Cancer: Adjuvant DXP [Phase 2]
Phase 2 trial evaluating adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin (DXP) in patients with resected advanced gastric …
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line Chemotherapy [Phase 2]
Phase 2 trial evaluating AZD5363 in combination with paclitaxel for advanced gastric adenocarcinoma with PIK3CA mutation or amplification; s…
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating MK-3475 (pembrolizumab) in combination with INCB024360 in various selected cancers; study completed with results …
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Tripletrumab Combined With Oxaliplatin and Teggio (SOX) in First-line Treatment of Gastric and Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial evaluating tripletrumab plus SOX as first-line treatment for gastric cancer and gastroesophageal junction adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2019-12-11Clinical Trial Update: Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial update for autologous CAR-T/TCR-T cell immunotherapy targeting multiple malignancies; current status is unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma [Phase 2]
A Phase 2 trial evaluating a modified DCF regimen (docetaxel, cisplatin, and fluorouracil) in unresectable or metastatic gastric and gastroe…
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Camrelizumab, Apatinib and Nab-paclitaxel as Second-line Treatment in Advanced Gastric Cancer [Phase 1, Phase 2]
Clinical trial update on camrelizumab, apatinib, and nab-paclitaxel as second-line treatment for advanced gastric cancer in Phase 1/2.
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: Clinical Study of Propranolol Combined With Neoadjuvant Chemotherapy in Gastric Cancer [Phase 2]
Phase 2 clinical trial investigating propranolol in combination with neoadjuvant chemotherapy for gastric cancer.
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Preoperative Intravenous Iron Therapy in Patients With Gastric Cancer [Phase 4]
Phase 4 clinical trial evaluating preoperative intravenous iron therapy in patients with gastric cancer and anemia.
-
CLINICAL_TRIALS trial_result · 2019-11-18Clinical Trial Update: Genotype Guided Chemotherapy in Gastric Cancer Patients [Phase 2]
Phase 2 trial investigating genotype-guided chemotherapy in metastatic gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-13Clinical Trial Update: Safety and Efficacy of γδ T Cell Against Gastric Cancer [Phase 1, Phase 2]
A clinical trial update reports safety and efficacy data for γδ T cell therapy targeting gastric cancer in Phase 1/2.
-
CLINICAL_TRIALS trial_result · 2019-11-07Clinical Trial Update: POF Versus FOLFOX Plus IP Paclitaxel in AGC [Phase 2]
Phase 2 clinical trial comparing POF regimen versus FOLFOX plus IP paclitaxel in advanced gastric cancer is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Neoadjuvant POF in the Treatment of Locally Advanced Gastric Cancer [Phase 2]
Phase 2 neoadjuvant POF regimen trial for locally advanced gastric cancer is in progress with unknown status.
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer [Phase 3]
A randomized Phase III trial comparing POF with SOX/CAPOX/FOLFOX as postoperative adjuvant chemotherapy for curatively resected stage III ga…
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer [Phase 3]
A Phase 3 trial comparing Low-Tox vs Eox in locally advanced unresectable or metastatic gastric cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab With Chemoradiotherapy in the Adjuvant Setting in Operated Participants With Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Gastric or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial evaluating oxaliplatin, capecitabine, and trastuzumab with chemoradiotherapy as adjuvant therapy in operable HER2-positive gas…
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: 64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer [NA]
Clinical trial evaluating 64Cu DOTA-Trastuzumab PET/CT imaging in patients with gastric cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-18Clinical Trial Update: Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma [Phase 2]
Phase 2 trial evaluating capecitabine, carboplatin, and bevacizumab for gastroesophageal junction and gastric cancer has completed, with res…
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Apatinib Plus Sintilimab in Advanced Gastric Cancer Refractory to at Least Two Previous Chemotherapy Regimens [Phase 2]
Phase 2 trial evaluating apatinib plus sintilimab in advanced gastric cancer that is refractory to at least two prior chemotherapies.
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal Metastasis [Phase 3]
Phase 3 clinical trial evaluating cytoreductive surgery with HIPEC and chemotherapy for gastric cancer with peritoneal metastasis.
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer [Phase 2]
A phase 2 trial evaluating FDG-PET directed treatment for locally advanced gastric and gastroesophageal junction adenocarcinoma was terminat…
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Clinical Trial of Chemotherapy Combination Cisplatin-Fluorouracil-Afatinib in Patients With Inoperable Gastric Cancer [Phase 2]
Phase 2 trial assessing a chemotherapy combination (cisplatin-fluorouracil-afatinib) in patients with inoperable gastric or gastroesophageal…
-
CLINICAL_TRIALS trial_result · 2019-08-30Clinical Trial Update: Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy [Phase 4]
A Phase 4 trial comparing berberine-amoxicillin quadruple therapy to tetracycline-furazolidone quadruple therapy for Helicobacter pylori-rel…
-
CLINICAL_TRIALS trial_result · 2019-08-29Clinical Trial Update: S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial update of S1201 evaluating combination chemotherapy for advanced or metastatic esophageal, gastric, or gastroesophageal juncti…
-
CLINICAL_TRIALS trial_result · 2019-08-29Clinical Trial Update: Gastrectomy, Eating Behaviour and GLP-1 [NA]
Completed clinical trial examining gastrectomy, eating behavior, and GLP-1 related to gastric cancer and dumping syndrome; results posted in…